Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Original Research

Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma

       
Total article views   HTML views PDF downloads Totals
2,928 Dovepress* 2,766+ 63 2,829
PubMed Central* 162 56 218
Totals 2,928 119 3,047
*Since 2 March 2023

View citations on PubMed Central and Google Scholar